We are here to modernize
Fertility care made easy
Champions the move to local doctor’s offices without the need or expense of a specialized clinic.
Eliminates the need for surgery and associated specialists/costs: surgical theater, anesthesia, etc.
Creates a game-changing
low-cost alternative to
Opens and expands multiple, global universally-unserved fertility and infertility markets.
Develop novel technologies enabling everyone to access safe, effective, and affordable fertility and gynecologic care.
Our unique technology enables an enhanced IVF clinical experience. Through visualization, tip articulation, device miniaturization, and AI/ML driven intrauterine insights, we simplify the process of performing intrauterine procedures and enhance the patient experience.
Butterfly is focused on optimizing embryo implantation through our visual embryo transfer system which provides direct visualization of catheter placement in the uterus, and by reducing risk of undetected pathologies that might otherwise lead to failed IVF cycles.
We are currently pre-market and have reached a minimum viable product for our product utilizations of embryo transfer and visual saline infusion sonography.
Commercialization will commence in 2025 upon FDA 510K clearance.